Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Blumberg

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
Molecular Carcinogenesis|February 10, 2016
Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skinJessica S Kelsey, Christophe Cataisson, Jinqiu Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2017
Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonistsSunho Lee, Changhoon Kim, Jihyae Ann, et al.
Plos One|August 31, 2013
RasGRPs are targets of the anti-cancer agent ingenol-3-angelateXiaohua Song, Ana Lopez-Campistrous, Lucy Sun, et al.
The Journal of Biological Chemistry|October 5, 2001
Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalphaMaria Laura Garcia-Bermejo, Federico Coluccio Leskow, Teruhiko Fujii, et al.
Chembiochem : a European Journal of Chemical Biology|May 5, 2011
Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cellsNoemi Kedei, Emanuel Lubart, Nancy E Lewin, et al.
Molecular Pharmacology|June 24, 2004
PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol estersChaya Brodie, Rivka Steinhart, Gila Kazimirsky, et al.
Journal of Medicinal Chemistry|February 8, 2002
Structural basis of RasGRP binding to high-affinity PKC ligandsSuo-Bao Rong, Istvan J Enyedy, Lixin Qiao, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2020
Discovery of 1-(1H-indazol-4-yl)-3-((1-phenyl-1H-pyrazol-5-yl)methyl) ureas as potent and thermoneutral TRPV1 antagonistsJin Mi Kang, Sun Ok Kwon, Jihyae Ann, et al.
The Journal of Biological Chemistry|March 30, 2016
Structural Basis for the Failure of the C1 Domain of Ras Guanine Nucleotide Releasing Protein 2 (RasGRP2) to Bind Phorbol Ester with High AffinityAgnes Czikora, Daniel J Lundberg, Adelle Abramovitz, et al.
Cancer Research|September 30, 2010
RasGRP3 contributes to formation and maintenance of the prostate cancer phenotypeDazhi Yang, Noemi Kedei, Luowei Li, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Molecular Carcinogenesis|February 10, 2016
Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skinJessica S Kelsey, Christophe Cataisson, Jinqiu Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2017
Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonistsSunho Lee, Changhoon Kim, Jihyae Ann, et al.
Plos One|August 31, 2013
RasGRPs are targets of the anti-cancer agent ingenol-3-angelateXiaohua Song, Ana Lopez-Campistrous, Lucy Sun, et al.
The Journal of Biological Chemistry|October 5, 2001
Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalphaMaria Laura Garcia-Bermejo, Federico Coluccio Leskow, Teruhiko Fujii, et al.
Chembiochem : a European Journal of Chemical Biology|May 5, 2011
Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cellsNoemi Kedei, Emanuel Lubart, Nancy E Lewin, et al.
Molecular Pharmacology|June 24, 2004
PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol estersChaya Brodie, Rivka Steinhart, Gila Kazimirsky, et al.
Journal of Medicinal Chemistry|February 8, 2002
Structural basis of RasGRP binding to high-affinity PKC ligandsSuo-Bao Rong, Istvan J Enyedy, Lixin Qiao, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2020
Discovery of 1-(1H-indazol-4-yl)-3-((1-phenyl-1H-pyrazol-5-yl)methyl) ureas as potent and thermoneutral TRPV1 antagonistsJin Mi Kang, Sun Ok Kwon, Jihyae Ann, et al.
The Journal of Biological Chemistry|March 30, 2016
Structural Basis for the Failure of the C1 Domain of Ras Guanine Nucleotide Releasing Protein 2 (RasGRP2) to Bind Phorbol Ester with High AffinityAgnes Czikora, Daniel J Lundberg, Adelle Abramovitz, et al.
Cancer Research|September 30, 2010
RasGRP3 contributes to formation and maintenance of the prostate cancer phenotypeDazhi Yang, Noemi Kedei, Luowei Li, et al.
Pageof 19